Cargando…
Marked Sinus Bradycardia Associated With Remdesivir in COVID-19: A Case and Literature Review
Remdesivir has seen extensive use during the coronavirus disease-2019 pandemic given its clinically proven efficacy against severe acute respiratory syndrome coronavirus type 2. There has been little cited regarding adverse effects. Here we present the case of a patient with marked sinus bradycardia...
Autores principales: | Gubitosa, James C., Kakar, Parul, Gerula, Christine, Nossa, Hernando, Finkel, Diana, Wong, Kristin, Khatri, Megna, Ali, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598346/ https://www.ncbi.nlm.nih.gov/pubmed/33163977 http://dx.doi.org/10.1016/j.jaccas.2020.08.025 |
Ejemplares similares
-
Remdesivir-Induced Marked Sinus Bradycardia in COVID-19
por: Ahmed, Taimoor, et al.
Publicado: (2022) -
Remdesivir: Sinus bradycardia: case report
Publicado: (2021) -
Remdesivir: Sinus bradycardia: case report
Publicado: (2022) -
Remdesivir: Sinus bradycardia: case report
Publicado: (2022) -
Remdesivir: Sinus bradycardia: case report
Publicado: (2021)